Clin2
NCT07326839Possibly a fitNot yet recruiting

Weight-loss drug and diet help lower uric acid in gout

GoutObesity

Treatments studied

Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.

This trial tests whether the weight-loss drug orlistat, along with weight management, helps lower uric acid levels in people who have both gout and obesity. If you qualify, you may receive orlistat or a placebo to see if it reduces gout flare-ups and improves your uric acid control.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have been diagnosed with gout by a doctor.
  • Your body mass index (BMI) is 28 or higher, which falls in the obese range.
  • Your blood uric acid level is very high (480 μmol/L or more).
  • You are willing to follow the study plan and attend follow-up visits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07824895Not yet recruiting· Phase 4
Weight loss and gout treatment for adults with obesity

This trial tests a new medication, mazdutide, that may help with both weight loss and managing gout flares. If you are an adult with obesity and have had recent gout attacks, this study could offer a new treatment option.

NCT04875702Recruiting· Phase 4
Compare urate targets to reduce gout attacks or symptoms

This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.

South Birmingham, Alabama
NCT06622603Recruiting· Phase 4
Testing lower doses of febuxostat in well-controlled gout

This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.

Seongnam-si, Gyeonggi-do
NCT07834840Enrolling by invitation
Diet education for gout patients on urate-lowering therapy

This trial tests whether extra diet advice helps people with gout who are already taking urate-lowering medicine. It might help them manage their condition better.

Suwon, Gyeonggi-do
NCT07362355Recruiting· Phase 2
New gout pill combined with febuxostat for high uric acid

This trial tests an experimental tablet (SHR4640) added to the standard gout medicine febuxostat (40 mg daily) for people whose uric acid remains too high despite febuxostat alone. The goal is to see if the combination lowers uric acid more effectively and safely.

Shanghai, Shanghai Municipality
NCT07141888Recruiting
Probiotic supplement for high uric acid

This study tests whether a probiotic food supplement can lower high uric acid levels, which often cause gout. It might help you if your uric acid is high but you haven't had a recent gout attack.

Örebro

Hear when a new Gout trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.